258 related articles for article (PubMed ID: 30959220)
1. The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.
Felten R; Scher F; Sibilia J; Gottenberg JE; Arnaud L
Autoimmun Rev; 2019 Jun; 18(6):576-582. PubMed ID: 30959220
[TBL] [Abstract][Full Text] [Related]
2. The Future of Targeted Treatment of Primary Sjögren's Syndrome: A Focus on Extra-Glandular Pathology.
Zeng W; Zhou X; Yu S; Liu R; Quek CWN; Yu H; Tay RYK; Lin X; Feng Y
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430611
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Sjögren's syndrome: current therapy and future directions.
Fox RI; Fox CM; Gottenberg JE; Dörner T
Rheumatology (Oxford); 2021 May; 60(5):2066-2074. PubMed ID: 31034046
[TBL] [Abstract][Full Text] [Related]
4. Biologic treatments in Sjögren's syndrome.
Bowman S; Barone F
Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
[TBL] [Abstract][Full Text] [Related]
5. Use of Biologics in Sjögren's Syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
[TBL] [Abstract][Full Text] [Related]
6. Targeting primary Sjögren's syndrome.
Odani T; Chiorini JA
Mod Rheumatol; 2019 Jan; 29(1):70-86. PubMed ID: 30424703
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in primary Sjögren's syndrome: a ten-year journey.
Carubbi F; Alunno A; Cipriani P; Bartoloni E; Ciccia F; Triolo G; Gerli R; Giacomelli R
Lupus; 2014 Nov; 23(13):1337-49. PubMed ID: 25096066
[TBL] [Abstract][Full Text] [Related]
8. Present and novel biologic drugs in primary Sjögren's syndrome.
Fasano S; Isenberg DA
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):167-174. PubMed ID: 31025931
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy for Primary Sjögren's Syndrome: Where are We Now?
Wang B; Chen S; Li Y; Xuan J; Liu Y; Shi G
BioDrugs; 2021 Nov; 35(6):593-610. PubMed ID: 34731460
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD20 antibody in primary Sjögren's syndrome management.
Chen S; Liu Y; Shi G
Curr Pharm Biotechnol; 2014; 15(6):535-41. PubMed ID: 25213362
[TBL] [Abstract][Full Text] [Related]
11. Safety of treatments for primary Sjögren's syndrome.
van Nimwegen JF; Moerman RV; Sillevis Smitt N; Brouwer E; Bootsma H; Vissink A
Expert Opin Drug Saf; 2016; 15(4):513-24. PubMed ID: 26809028
[TBL] [Abstract][Full Text] [Related]
12. Biologic therapies in primary Sjögren's syndrome.
Bowman SJ
Curr Pharm Biotechnol; 2012 Aug; 13(10):1997-2008. PubMed ID: 22208654
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome.
Kaufman I; Schwartz D; Caspi D; Paran D
Scand J Rheumatol; 2008; 37(3):213-8. PubMed ID: 18465457
[TBL] [Abstract][Full Text] [Related]
14. Primary Sjogren's syndrome: current and prospective therapies.
Thanou-Stavraki A; James JA
Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.
Mariette X; Seror R; Quartuccio L; Baron G; Salvin S; Fabris M; Desmoulins F; Nocturne G; Ravaud P; De Vita S
Ann Rheum Dis; 2015 Mar; 74(3):526-31. PubMed ID: 24347569
[TBL] [Abstract][Full Text] [Related]
16. New biological therapies in Sjögren's syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):783-93. PubMed ID: 27107513
[TBL] [Abstract][Full Text] [Related]
17. Current and future therapies for primary Sjögren syndrome.
Seror R; Nocturne G; Mariette X
Nat Rev Rheumatol; 2021 Aug; 17(8):475-486. PubMed ID: 34188206
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
19. Future treatments for Sjögren's syndrome.
Pers JO; Saraux A
Presse Med; 2016 Jun; 45(6 Pt 2):e193-200. PubMed ID: 27242213
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for primary Sjögren's syndrome.
Gandolfo S; De Vita S
Expert Opin Emerg Drugs; 2019 Jun; 24(2):121-132. PubMed ID: 31286787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
